Background. This paper presents data on breast cancer prevalence and mortality among US Hispanics and Hispanic subgroups, including Cuban, Mexican, Puerto Rican, Central American, and South American. Methods. Five-year average annual female breast cancer prevalence and mortality rates for 2009–2013 were examined using data from the National Health Interview Survey (prevalence) and the National Center for Health Statistics and the American Community Survey (mortality rates). Results. Overall breast cancer prevalence among US Hispanic women was 1.03%. Although the estimates varied slightly by Hispanic subgroup, these differences were not statistically significant. The breast cancer mortality rate for Hispanics overall was 17.71 per 100,000 wo...
BACKGROUND: Cancer survival is a key indicator of the effectiveness and social justice of health ser...
While the associations of common metabolic conditions with ethnicity have been previously described,...
ObjectivesLatina breast cancer patients are 20 percent more likely to die within 5 years after diagn...
Introduction: National data on the epidemiology of cancer are commonly reported by broad racial/ethn...
Introduction: National data on the epidemiology of cancer are commonly reported by broad racial/ethn...
Introduction: National data on the epidemiology of cancer are commonly reported by broad racial/ethn...
Cancer is the leading cause of death among Hispanics/Latinos, who represent the largest racial/ethni...
variation in incidence rates for two cancers common in US Hispanic women and consid-ered some potent...
This report summarizes statistics on cancer incidence, mortality, survival, risk factors, and early ...
PurposeTo assess tumor subtype distribution and the relative contribution of clinical and sociodemog...
Variation in breast cancer occurrence among women in New Mexico's three major ethnic groups has...
Despite multiple campaigns by the American Cancer Society, reports indicate that Latinas living in t...
Despite multiple campaigns by the American Cancer Society, reports indicate that Latinas living in t...
Despite multiple campaigns by the American Cancer Society, reports indicate that Latinas living in t...
Cancer afflicts 1.4 million people in the United States annually. In 2007, 45.5 million Hispanics we...
BACKGROUND: Cancer survival is a key indicator of the effectiveness and social justice of health ser...
While the associations of common metabolic conditions with ethnicity have been previously described,...
ObjectivesLatina breast cancer patients are 20 percent more likely to die within 5 years after diagn...
Introduction: National data on the epidemiology of cancer are commonly reported by broad racial/ethn...
Introduction: National data on the epidemiology of cancer are commonly reported by broad racial/ethn...
Introduction: National data on the epidemiology of cancer are commonly reported by broad racial/ethn...
Cancer is the leading cause of death among Hispanics/Latinos, who represent the largest racial/ethni...
variation in incidence rates for two cancers common in US Hispanic women and consid-ered some potent...
This report summarizes statistics on cancer incidence, mortality, survival, risk factors, and early ...
PurposeTo assess tumor subtype distribution and the relative contribution of clinical and sociodemog...
Variation in breast cancer occurrence among women in New Mexico's three major ethnic groups has...
Despite multiple campaigns by the American Cancer Society, reports indicate that Latinas living in t...
Despite multiple campaigns by the American Cancer Society, reports indicate that Latinas living in t...
Despite multiple campaigns by the American Cancer Society, reports indicate that Latinas living in t...
Cancer afflicts 1.4 million people in the United States annually. In 2007, 45.5 million Hispanics we...
BACKGROUND: Cancer survival is a key indicator of the effectiveness and social justice of health ser...
While the associations of common metabolic conditions with ethnicity have been previously described,...
ObjectivesLatina breast cancer patients are 20 percent more likely to die within 5 years after diagn...